Study Confirms Increased CVT With AstraZeneca COVID Vaccine

Rates of cerebral venous thrombosis and thrombocytopenia were higher in patients who received the AstraZeneca COVID-19 vaccine in three Nordic countries.
Medscape Medical News

source https://www.medscape.com/viewarticle/976487?src=rss